Public Health Implications of Smokeless Tobacco Use as a Harm Reduction Strategy
Bibliographic Data
Harm reduction strategies involve promoting a product that has adverse health consequences as a substitute for one that has more severe adverse health consequences. Smokeless tobacco low in nitrosamine content offers potential benefits in reducing smoking prevalence rates. Possible harm arises from the potential for such products to serve as a gateway to more harmful tobacco products, public misinterpretation of “less harmful” as “safe,” distraction from the public health goal of tobacco elimination, and ethical issues involved in advising those marketing these harmful products. We offer a research agenda to provide a stronger basis for evaluating the risks and benefits of smokeless tobacco as a means of reducing the adverse health effects of tobacco
Environmental health · Harm · Harm reduction · Political science · Public health · Smokeless tobacco · Snus · Tobacco control · Tobacco harm reduction · Tobacco use · Air Quality and Health Impacts · Coffee research and impacts · Medicine · Nursing · Smoking Behavior and Cessation
Tobacco industry co-optation of culture? Converging culturally specific and mainstream tobacco products in India
Smokeless and combustible tobacco use among 148,944 South Asian adults
Snus use and rejection in the USA
Practitioners’ Views on Nicotine Replacement Therapy in Pregnancy during Lapse and for Harm Reduction
Interviews with smokers about smokeless tobacco products, risk messages and news articles
Relative harm of snus and cigarettes
The Strategic Dialogue on Tobacco Harm Reduction
Relative Risk Perceptions between Snus and Cigarettes in a Snus-Prevalent Society—An Observational Study over a 16 Year Period
Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco
Quantifying the effects of promoting smokeless tobacco as a harm reduction strategy in the USA
Smokeless tobacco industry's brand stretching through FM radio
Factors influencing national public health governance capacity
Betel Quid Addiction
Determinants of initiation, continuation and cessation of smokeless tobacco use among pregnant and lactating women
Withholding differential risk information on legal consumer nicotine/tobacco products
The incentives created by a harm reduction approach to smoking cessation
Prevalence of Trial of Snus Products Among Adult Smokers
| Citations per year | 0.94 |
|---|---|
| Citation span | 2008 - 2025 (18) |
| Highly cited | No |